Amedeo Smart

Free Medical Literature Service


 

Amedeo

Gastric Cancer

  Free Subscription

Articles published in
Cancer Res
    December 2023
  1. TU RH, Wu SZ, Huang ZN, Zhong Q, et al
    Neurotransmitter Receptor HTR2B Regulates Lipid Metabolism to Inhibit Ferroptosis in Gastric Cancer.
    Cancer Res. 2023;83:3868-3885.
    >> Share

    September 2023
  2. FAN Y, Song S, Li Y, Dhar SS, et al
    Galectin-3 Cooperates with CD47 to Suppress Phagocytosis and T cell Immunity in Gastric Cancer Peritoneal Metastases.
    Cancer Res. 2023 Sep 22. doi: 10.1158/0008-5472.CAN-23-0783.
    >> Share

    August 2023
  3. YE H, Shi W, Yang J, Wang L, et al
    PICH activates Cyclin A1 transcription to drive S-phase progression and chemoresistance in gastric cancer.
    Cancer Res. 2023 Aug 30. doi: 10.1158/0008-5472.CAN-23-1331.
    >> Share

    May 2023
  4. PETRELLI A, Rizzolio S, Pietrantonio F, Bellomo SE, et al
    BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors.
    Cancer Res. 2023 May 2:OF1-OF12. doi: 10.1158/0008-5472.CAN-22-2620.
    >> Share

    March 2023
  5. NARGUND AM, Xu C, Mandoli A, Okabe A, et al
    Correction: Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer.
    Cancer Res. 2023;83:804.
    >> Share

  6. TAURIELLO DVF
    Targeting CAFs to Improve Anti-PD-1 Checkpoint Immunotherapy.
    Cancer Res. 2023;83:655-656.
    >> Share

  7. AKIYAMA T, Yasuda T, Uchihara T, Yasuda-Yoshihara N, et al
    Stromal Reprogramming through Dual PDGFRalpha/beta Blockade Boosts the Efficacy of Anti-PD-1 Immunotherapy in Fibrotic Tumors.
    Cancer Res. 2023;83:753-770.
    >> Share

    December 2022
  8. SHEN Y, Zhang N, Chai J, Wang T, et al
    CircPDIA4 induces gastric cancer progression by promoting ERK1/2 activation and enhancing biogenesis of oncogenic circRNAs.
    Cancer Res. 2022 Dec 23:CAN-22-1923. doi: 10.1158/0008-5472.CAN-22-1923.
    >> Share

    November 2022
  9. LLORCA-CARDENOSA MJ, Aronson LI, Krastev DB, Nieminuszczy J, et al
    SMG8/SMG9 Heterodimer Loss Modulates SMG1 Kinase to Drive ATR Inhibitor Resistance.
    Cancer Res. 2022;82:3962-3973.
    >> Share

  10. O'LEARY PC, Chen H, Doruk YU, Williamson T, et al
    Resistance to ATR Inhibitors Is Mediated by Loss of the Nonsense-Mediated Decay Factor UPF2.
    Cancer Res. 2022;82:3950-3961.
    >> Share

    May 2022
  11. NARGUND AM, Xu C, Mandoli A, Okabe A, et al
    Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer.
    Cancer Res. 2022 May 18. pii: 699013. doi: 10.1158/0008-5472.CAN-21-2072.
    >> Share

  12. KUMAGAI K, Shimizu T, Takai A, Kakiuchi N, et al
    Expansion of Gastric Intestinal Metaplasia with Copy Number Aberrations Contributes to Field Cancerization.
    Cancer Res. 2022;82:1712-1723.
    >> Share

    March 2022
  13. DUAN X, Chen H, Zhou X, Liu P, et al
    EBV Infection in Epithelial Malignancies Induces Resistance to Antitumor Natural Killer Cells via F3-Mediated Platelet Aggregation.
    Cancer Res. 2022;82:1070-1083.
    >> Share

  14. WANG J, Huang Q, Hu X, Zhang S, et al
    Disrupting circadian rhythm via the PER1-HK2 axis reverses trastuzumab resistance in gastric cancer.
    Cancer Res. 2022 Mar 7. pii: 682075. doi: 10.1158/0008-5472.CAN-21-1820.
    >> Share

    December 2021
  15. JUN Y, Suh YS, Park S, Lee J, et al
    Comprehensive analysis of alternative splicing in gastric cancer identifies epithelial-mesenchymal transition subtypes associated with survival.
    Cancer Res. 2021 Dec 13. pii: 0008-5472.CAN-21-2117.
    >> Share

    August 2021
  16. VAN DONGEN GAMS
    Improving Tumor Penetration of Antibodies and Antibody-Drug Conjugates: Taking Away the Barriers for Trojan Horses.
    Cancer Res. 2021;81:3956-3957.
    >> Share

    February 2021
  17. AN O, Song Y, Ke X, So JB, et al
    "3G" Trial: An RNA Editing Signature to Guide Gastric Cancer Chemotherapy.
    Cancer Res. 2021 Feb 8. pii: 0008-5472.CAN-20-2872.
    >> Share

  18. GRUNBERG N, Pevsner-Fischer M, Goshen-Lago T, Diment J, et al
    Cancer-associated fibroblasts promote aggressive gastric cancer phenotypes via heat shock factor 1-mediated secretion of extracellular vesicles.
    Cancer Res. 2021 Feb 5. pii: 0008-5472.CAN-20-2756.
    >> Share

    December 2020
  19. WU S, Chen M, Huang J, Zhang F, et al
    ORAI2 Promotes Gastric Cancer Tumorigenicity and Metastasis Through PI3K/Akt Signaling and MAPK-dependent Focal Adhesion Disassembly.
    Cancer Res. 2020 Dec 11. pii: 0008-5472.CAN-20-0049.
    >> Share

    November 2020
  20. SOOTOME H, Fujita H, Ito K, Ochiiwa H, et al
    Futibatinib Is a Novel Irreversible FGFR 1-4 Inhibitor That Shows Selective Antitumor Activity against FGFR-Deregulated Tumors.
    Cancer Res. 2020;80:4986-4997.
    >> Share

    August 2020
  21. UCHIHARA T, Miyake K, Yonemura A, Komohara Y, et al
    Extracellular Vesicles from Cancer-Associated Fibroblasts Containing Annexin A6 Induces FAK-YAP Activation by Stabilizing beta1 Integrin, Enhancing Drug Resistance.
    Cancer Res. 2020;80:3222-3235.
    >> Share

    June 2020
  22. WANG SC, Yeu Y, Hammer STG, Xiao S, et al
    Hispanic/Latino Patients with Gastric Adenocarcinoma Have Distinct Molecular Profiles Including a High Rate of Germline CDH1 Variants.
    Cancer Res. 2020;80:2114-2124.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016